Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpa Vasishta

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cureus|August 15, 2019
Elevated Procalcitonin in Acute Pseudogout Flare: A Case ReportShilpa Vasishta, Satya Patel
Journal of Brown Hospital Medicine|March 3, 2025
Meant to BeBrenna Lilley, Shilpa Vasishta, Satya Patel
Journal of Acquired Immune Deficiency Syndromes (1999)|June 22, 2023
Brief Report: Hepatitis B Infection or Reactivation After Switch to 2-Drug Antiretroviral Therapy: A Case Series, Literature Review, and Management DiscussionShilpa Vasishta, Douglas Dieterich, Michael Mullen, et al.
Open Forum Infectious Diseases|October 16, 2024
Infectious Diseases Fellowship Training in Caring for People Who Use Drugs: A National Assessment of an Emerging Training NeedShilpa Vasishta, Raagini Jawa, Sarah Kurz, et al.
Therapeutic Advances in Infectious Disease|February 19, 2025
Clinical outcomes in immunocompromised adults with COVID-19, based on anti-spike IgG serostatus and monoclonal antibody therapy: a retrospective cohort study in the Omicron periodShilpa Vasishta, Judith Aberg, Gopi Patel, et al.
Open Forum Infectious Diseases|October 30, 2025
A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for the Switch to Two-Drug Antiretroviral Regimens in People With HIVMelissa Margolis, Shilpa Vasishta, Judith A Aberg, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cureus|August 15, 2019
Elevated Procalcitonin in Acute Pseudogout Flare: A Case ReportShilpa Vasishta, Satya Patel
Journal of Brown Hospital Medicine|March 3, 2025
Meant to BeBrenna Lilley, Shilpa Vasishta, Satya Patel
Journal of Acquired Immune Deficiency Syndromes (1999)|June 22, 2023
Brief Report: Hepatitis B Infection or Reactivation After Switch to 2-Drug Antiretroviral Therapy: A Case Series, Literature Review, and Management DiscussionShilpa Vasishta, Douglas Dieterich, Michael Mullen, et al.
Open Forum Infectious Diseases|October 16, 2024
Infectious Diseases Fellowship Training in Caring for People Who Use Drugs: A National Assessment of an Emerging Training NeedShilpa Vasishta, Raagini Jawa, Sarah Kurz, et al.
Therapeutic Advances in Infectious Disease|February 19, 2025
Clinical outcomes in immunocompromised adults with COVID-19, based on anti-spike IgG serostatus and monoclonal antibody therapy: a retrospective cohort study in the Omicron periodShilpa Vasishta, Judith Aberg, Gopi Patel, et al.
Open Forum Infectious Diseases|October 30, 2025
A Quality Improvement Pilot to Increase Hepatitis B Screening and Optimize Patient Selection for the Switch to Two-Drug Antiretroviral Regimens in People With HIVMelissa Margolis, Shilpa Vasishta, Judith A Aberg, et al.
Pageof 1